Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B Trial. (2021)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/2159-8290.cd-21-0007

PubMed Identifier: 34045297

Publication URI: http://europepmc.org/abstract/MED/34045297

Type: Journal Article/Review

Volume: 11

Parent Publication: Cancer discovery

Issue: 11

ISSN: 2159-8274